Posted: 2020-11-25 14:47
Eloel Saget (AFP / “Scanpix”) now
Moderna, which is developing a coronavirus vaccine, announced that it has signed an agreement with the European Commission (EC) for the first 80 million doses of the KOVID-19 mRNA vaccine. additional doses.
“We appreciate the European Commission’s trust in our mRNA vaccine platform by including mRNA-1273 in its vaccine portfolio. “We understand that many solutions will be needed to overcome this global pandemic, and we are proud of the role of Moderna in this global operation,” said Stefan Bansel, CEO of Moderna, in a statement released by the company.
M.Sc. has already written that data from clinical trials in phase III show that the Modern vaccine is 95% effective, and its licensing has already been applied to the US Department of Food and Drug Administration.
“We have expanded production capacity outside the United States with our strategic partners to deliver approximately 500 million doses per year and possibly up to 1 billion doses per year by 2021 if the vaccine is approved,” the report added.
VŽ has already written that Brussels has already signed contracts to buy hundreds of millions of possible vaccine doses in the future from Johnson & Johnson, Sanofi-GSK, AstraZeneca, Pfizer-BionNTech and CureVac.
Ursula von der Leyen, president of the European Commission, said the European Medicines Agency (EMA) could approve the first potential coronavirus vaccines, for which clinical trial results have already been submitted, later this year or early next year.
write a comment